Frequently asked questions: testing for HIV, including HIV self-testing, in the context of pre-exposure prophylaxis (‎PrEP)

1 October 2017
 | Advocacy brief
Frequently asked questions: testing for HIV, including HIV self-testing, in the context of pre-exposure prophylaxis (‎PrEP)
Download (164.4 kB)

Overview

This document is intended for testing providers, and for HTS clients. HIV testing in the context of antiretroviral (ARV) drugs has become complex.

  1. Although not recommended, individuals with a known HIV-positive status on antiretroviral therapy (ART) may seek HIV testing services to “check” their HIV status.

  2. Individuals who are HIV-negative and take ARVs (i.e. oral pre-exposure prophylaxis (PrEP)) to prevent HIV acquisition are recommended to test quarterly.

This set of frequently asked questions will focus on the second situation

Related

HIV testing services

WHO Team
Access to Medicines and Health Products (MHP), Global HIV, Hepatitis and STIs Programmes (HHS), Incidents and SF (ISF), Regulation and Prequalification (RPQ), Regulation and safety (REG)
Editors
World Health Organization
Number of pages
4
Reference numbers
WHO Reference Number: WHO/EMP/SAV/2018.06
Copyright